Label

How We Work

Grant

Back

Print

Sangamo BioSciences Inc


May 2009
to research the use of zinc finger nuclease technology to specifically disrupt the CCR5 gene as a new strategy to make people resistant to HIV
$100,000
12
Discovery and Translational Sciences
Global Health
Richmond, California

Visit Our Blog